Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126499512 | 12649951 | 2 | F | 20160804 | 20160824 | 20160813 | 20160901 | EXP | NL-AMGEN-NLDSL2016102540 | AMGEN | 71.00 | YR | E | M | Y | 0.00000 | 20160901 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126499512 | 12649951 | 1 | PS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 250 MUG, QWK | U | 1067233D | 125268 | 250 | UG | POWDER FOR INJECTION | /wk | ||||
| 126499512 | 12649951 | 2 | SS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | UNK | U | 1069683 | 125268 | POWDER FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126499512 | 12649951 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126499512 | 12649951 | HO |
| 126499512 | 12649951 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126499512 | 12649951 | Hospitalisation | |
| 126499512 | 12649951 | Intentional product misuse | |
| 126499512 | 12649951 | Platelet count decreased | |
| 126499512 | 12649951 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |